Evidence map›Paper›PMID 35291527›Full record

ArticleCureus2022

Vesicular Rash Following Immunisation With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine: Vaccine Related or Coincidence?

Mohd Radzniwan A Rashid, Sharifah Najwa Syed Mohamad, Anu Suria, Rokiah Shahra

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mohd Radzniwan A RashidDepartment of Primary Healthcare, Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia, Nilai, MYS.
Sharifah Najwa Syed MohamadDepartment of Primary Healthcare, Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia, Nilai, MYS.
Anu SuriaDepartment of Primary Healthcare, Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia, Nilai, MYS.
Rokiah ShahraDepartment of Family Medicine, Poliklinik Kesihatan, Universiti Sains Islam Malaysia (USIM) Healthcare, Nilai, MYS.
Universiti Sains Islam Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The introduction of the COVID-19 vaccines has led to an immense sense of relief for the global population. However, since the introduction of these vaccines, there have been several reports related to the side effects. A young woman presented to her primary care doctor with a vesicular rash three days after the BNT162b2 messenger RNA (mRNA) Pfizer-BioNTech vaccine, which was preceded by a low-grade fever for one day. Our case report highlights the challenges in diagnosing a vesicular rash post the BNT162b2 mRNA vaccine. Identifying the cause of a vesicular rash following vaccination has remained a challenge among primary care practitioners.

Indexed as

adverse eventscovid-19covid-19 vaccinepost-vaccine rashvesicular rash

Identifiers

PMID35291527
PMCPMC8918091
OpenAlexW4211217310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.